HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.

Abstract
The assumption that each enzyme expresses a single enzymatic activity in vivo is challenged by the linkage of the neuronal enzyme ubiquitin C-terminal hydrolase-L1 (UCH-L1) to Parkinson's disease (PD). UCH-L1, especially those variants linked to higher susceptibility to PD, causes the accumulation of alpha-synuclein in cultured cells, an effect that cannot be explained by its recognized hydrolase activity. UCH-L1 is shown here to exhibit a second, dimerization-dependent, ubiquityl ligase activity. A polymorphic variant of UCH-L1 that is associated with decreased PD risk (S18Y) has reduced ligase activity but comparable hydrolase activity as the wild-type enzyme. Thus, the ligase activity as well as the hydrolase activity of UCH-L1 may play a role in proteasomal protein degradation, a critical process for neuronal health.
AuthorsYichin Liu, Lara Fallon, Hilal A Lashuel, Zhihua Liu, Peter T Lansbury Jr
JournalCell (Cell) Vol. 111 Issue 2 Pg. 209-18 (Oct 18 2002) ISSN: 0092-8674 [Print] United States
PMID12408865 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Nerve Tissue Proteins
  • SNCA protein, human
  • Snca protein, rat
  • Synucleins
  • alpha-Synuclein
  • Thiolester Hydrolases
  • Ubiquitin Thiolesterase
  • Ligases
Topics
  • Animals
  • Brain Chemistry
  • COS Cells
  • Dimerization
  • Gene Dosage
  • Genetic Predisposition to Disease
  • Humans
  • Ligases (metabolism)
  • Models, Molecular
  • Mutation
  • Nerve Tissue Proteins (metabolism)
  • Parkinson Disease (genetics)
  • Polymorphism, Genetic
  • Rabbits
  • Rats
  • Synaptic Vesicles (chemistry)
  • Synucleins
  • Thiolester Hydrolases (analysis, genetics)
  • Transfection
  • Ubiquitin Thiolesterase
  • alpha-Synuclein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: